Related Experiment Video
Updated: Oct 19, 2025
04:55
Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
11.0K
Medication take-back programs in Qatar: Parental perceptions
Mohamed A Hendaus1,2,3, Shereen Darwish4, Manar Saleh4
1Department of Pediatrics Section of Academic General Pediatrics, Sidra Medicine, Doha, Qatar.
Journal of Family Medicine and Primary Care
|September 27, 2021
Summary
Most parents in Qatar keep unused medications at home and lack awareness of proper disposal methods. A majority would utilize a medication take-back program if available, highlighting a need for community health interventions.
Area of Science:
- Public Health
- Pharmaceutical Sciences
- Environmental Health
Background:
- Limited data exists on medication misuse and disposal practices in Qatar.
- Understanding parental medication disposal habits is crucial for child safety and environmental protection.
Purpose of the Study:
- To assess parental perceptions and knowledge regarding medication take-back programs.
- To identify current medication disposal practices among parents in Qatar.
Main Methods:
- A cross-sectional study was conducted using questionnaires at Hamad Medical Corporation.
- 305 parents completed the survey, yielding a 90% response rate.
Main Results:
- Nearly 60% of parents store unused medications at home; 95% dispose of expired medications, often in trash or drains.
- 75% of parents were unaware of medication take-back programs, yet 60% expressed willingness to use one.
- Only 10% consistently read medication disposal instructions.
Conclusions:
- Parents in Qatar demonstrate knowledge gaps concerning safe medication disposal.
- Parental attitudes toward medication management necessitate targeted community health interventions.
- Collaboration with the Ministry of Health is planned to raise awareness on proper medicine disposal and take-back programs.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
1.2K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
01:15Drug Dosing: Geriatric Patients
32
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
32
01:25Drug Regulation
2.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.1K
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
26
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
26
01:15Drug Abuse and Addiction: Pharmacological Phenomena
804
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
804
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
37
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37